JOURNAL ISSUE published June 2005 in Expert Opinion on Therapeutic Targets

JOURNAL ISSUE published February 2001 in Expert Opinion on Therapeutic Targets

Heat shock protein 70 – the next chaperone to target in the treatment of human acute myelogenous leukemia?

JOURNAL ARTICLE published August 2014 in Expert Opinion on Therapeutic Targets

Authors: Håkon Reikvam | Annette K Brenner | Ina Nepstad | André Sulen | Øystein Bruserud

Novel factors as therapeutic targets to treat diabetes. Focus on leptin and ghrelin

JOURNAL ARTICLE published May 2009 in Expert Opinion on Therapeutic Targets

Authors: Rodolfo Gómez | Francisca Lago | Juan J Gómez-Reino | Oreste Gualillo

Role of ‘shared epitope’ and other citrullination-sites in rheumatoid arthritis and in melanoma

JOURNAL ARTICLE published 3 October 2017 in Expert Opinion on Therapeutic Targets

Research funded by Ministry of Health (RC-2017-3.4)

Authors: Daniela D’Arcangelo | Antonio Facchiano | Angelo M. Facchiano

JOURNAL ISSUE published June 2007 in Expert Opinion on Therapeutic Targets

Related articles

JOURNAL ARTICLE published June 2013 in Expert Opinion on Therapeutic Targets

Novel therapeutic targets in osteoporosis

JOURNAL ARTICLE published February 2002 in Expert Opinion on Therapeutic Targets

Authors: JH Tobias | AM Flanagan | AM Scutt

(off)Targeting UPR signaling: the race toward intervening ER proteostasis

JOURNAL ARTICLE published February 2018 in Expert Opinion on Therapeutic Targets

Research funded by Comisión Nacional de Investigación Científica y Tecnológica (CONICYT-Brazil 441921/2016-7) | Comisión Nacional de Investigación Científica y Tecnológica (National Postgraduate Grant No. 21150769) | Comisión Nacional de Investigación Científica y Tecnológica (National Postdoctoral Grant No. 3170695) | Fondo Nacional de Desarrollo Científico y Tecnológico (1140549) | Instituto Millenium (P09-015-F) | Muscular Dystrophy Association (382453) | FONDAP Program (15150012) | ALSRPALSRP Therapeutic Idea (Award 81XWH-16-1-0112) | US Air Force Office of Scientific Research (FA9550-16-1-0384) | US OfficeUS Office of Naval Research-Global (N62909-16-1-2003)

Authors: Rodrigo Pérez-Arancibia | Alexis Rivas | Claudio Hetz

Adenosine signaling pathways as potential therapeutic targets in respiratory disease

JOURNAL ARTICLE published October 2013 in Expert Opinion on Therapeutic Targets

Authors: Massimo Caruso | Angela Alamo | Emanuele Crisafulli | Cirino Raciti | Alfredo Fisichella | Riccardo Polosa

TNF and congestive heart failure: therapeutic possibilities

JOURNAL ARTICLE published June 2004 in Expert Opinion on Therapeutic Targets

Authors: Jochen Müller-Ehmsen | Robert HG Schwinger

Emerging therapeutic strategies for transplantation-induced acute kidney injury: protecting the organelles and the vascular bed

JOURNAL ARTICLE published 3 June 2019 in Expert Opinion on Therapeutic Targets

Authors: Nicolas Melis | Raphael Thuillier | Clara Steichen | Sebastien Giraud | Yse Sauvageon | Jacques Kaminski | Thomas Pelé | Lionel Badet | Jean Pierre Richer | Jonatan Barrera-Chimal | Frédéric Jaisser | Michel Tauc | Thierry Hauet

Targeting signaling pathways in lung cancer therapy

JOURNAL ARTICLE published February 2013 in Expert Opinion on Therapeutic Targets

Authors: William CS Cho

Related articles

JOURNAL ARTICLE published September 2013 in Expert Opinion on Therapeutic Targets

5th annual conference on Cytokines and Inflammation

JOURNAL ARTICLE published July 2007 in Expert Opinion on Therapeutic Targets

Authors: Robert P Numerof | Eric Blasko

JOURNAL ISSUE published March 2007 in Expert Opinion on Therapeutic Targets

Related articles

JOURNAL ARTICLE published 3 April 2015 in Expert Opinion on Therapeutic Targets

JOURNAL ISSUE published December 1998 in Expert Opinion on Therapeutic Targets

Molecular targets for selective killing of TRAIL-resistant leukemic cells

JOURNAL ARTICLE published August 2011 in Expert Opinion on Therapeutic Targets

Authors: Giorgio Zauli | Raffaella Bosco | Paola Secchiero

JOURNAL ISSUE published April 2008 in Expert Opinion on Therapeutic Targets